Literature DB >> 9237602

Beta-blocker effects on postoperative atrial fibrillation.

I M Ali1, A A Sanalla, V Clark.   

Abstract

OBJECTIVES: To determine whether restarting of Beta Blocker following cardiac surgery would reduce the incidence and the severity of post-operative atrial fibrillation (AF).
METHODS: 210 patients who underwent elective coronary artery bypass grafting were randomized to control (C) (n = 105) and Beta Blockers (BB) (n = 105) groups. Preoperatively all patients were on one type or another of betablockers. Postoperatively only the (BB) group received the medication. Both groups were well matched and had the same cardioplegic technique.
RESULTS: It was found that; (1) post op (AF) developed in 40 patients of group (C) and in 18 patients of group (BB) P value < 0.02. (2) 73% of (AF) patients in group (C) and 81% in group (BB) were older than 70 years of age. (3) 76% of the (AF) in (BB) group versus 43% in (C) group were converted to sinus rhythm or to a stable controlled rhythm within 24 h or less. P value < 0.01.
CONCLUSIONS: The results indicate that restarting the Beta Blockers in the post-operative period after coronary bypass grafts significantly control the incidence and the severity of atrial fibrillation. Also it confirms the strong relation between the older age and (AF) occurrence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237602     DOI: 10.1016/s1010-7940(97)01215-3

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  17 in total

1.  Resource utilization related to atrial fibrillation after coronary artery bypass grafting.

Authors:  Marilyn Hravnak; Leslie A Hoffman; Melissa I Saul; Thomas G Zullo; Gayle R Whitman
Journal:  Am J Crit Care       Date:  2002-05       Impact factor: 2.228

Review 2.  Age as a Risk factor for Atrial Fibrillation and Flutter after Coronary Artery Bypass Grafting.

Authors:  Prashant Bhave; Rod Passman
Journal:  J Atr Fibrillation       Date:  2012-02-02

3.  A practical approach to the management of patients with atrial fibrillation.

Authors:  Christopher J McLeod; Bernard J Gersh
Journal:  Heart Asia       Date:  2010-09-06

4.  Association of postoperative complications and outcomes following coronary artery bypass grafting.

Authors:  Oliver K Jawitz; Brian C Gulack; J Matthew Brennan; Dylan P Thibault; Alice Wang; Sean M O'Brien; Jacob N Schroder; Jeffrey G Gaca; Peter K Smith
Journal:  Am Heart J       Date:  2020-02-08       Impact factor: 4.749

Review 5.  Postoperative atrial fibrillation: mechanism, prevention, and future perspective.

Authors:  Yasushige Shingu; Suguru Kubota; Satoru Wakasa; Tomonori Ooka; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Surg Today       Date:  2012-05-23       Impact factor: 2.549

6.  Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting.

Authors:  K Matsuura; Y Takahara; Y Sudo; K Ishida
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-10

7.  Prognostic factors of atrial fibrillation following coronary artery bypass graft surgery.

Authors:  Mantas Kievišas; Vytenis Keturakis; Egidijus Vaitiekūnas; Lukas Dambrauskas; Loreta Jankauskienė; Šarūnas Kinduris
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-24

8.  P-wave signal-averaged electrocardiogram predicts atrial fibrillation after coronary artery bypass grafting.

Authors:  Paolo Caravelli; Marco De Carlo; Giuseppe Musumeci; Giuseppe Tartarini; Gherardo Gherarducci; Uberto Bortolotti; Massimo A Mariani; Mario Mariani
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

9.  Effect of low-dose landiolol, an ultrashort-acting beta-blocker, on postoperative atrial fibrillation after CABG surgery.

Authors:  Hidenori Fujiwara; Masahiro Sakurai; Asako Namai; Takae Kawamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-03-12

10.  Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials.

Authors:  Muhammad Fahad Khan; Christopher S Wendel; Mohammad Reza Movahed
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-11-22       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.